SMG1
Basic information
Region (hg38): 16:18804860-18926408
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 23 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 6 | 5 |
Variants in SMG1
This is a list of pathogenic ClinVar variants found in the SMG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-18812121-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
16-18816363-A-G | not specified | Uncertain significance (Jul 28, 2021) | ||
16-18817390-C-T | Likely benign (Nov 01, 2022) | |||
16-18819585-A-G | Likely benign (Jan 01, 2023) | |||
16-18829459-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
16-18829977-T-C | not specified | Uncertain significance (Jul 06, 2021) | ||
16-18834273-T-C | Likely benign (Aug 14, 2018) | |||
16-18835939-T-C | not specified | Uncertain significance (Oct 29, 2021) | ||
16-18836186-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
16-18837383-A-G | Uncertain significance (Apr 01, 2022) | |||
16-18838114-T-C | not specified | Uncertain significance (Oct 06, 2021) | ||
16-18848040-T-A | Likely benign (Mar 01, 2018) | |||
16-18850274-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
16-18853610-A-C | not specified | Uncertain significance (Sep 01, 2021) | ||
16-18853684-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
16-18859071-T-A | not specified | Uncertain significance (Aug 02, 2021) | ||
16-18859589-A-G | not specified | Uncertain significance (Jul 14, 2021) | ||
16-18863720-C-A | Benign (Aug 14, 2018) | |||
16-18863836-G-C | not specified | Uncertain significance (Sep 14, 2021) | ||
16-18864053-T-A | not specified | Uncertain significance (Sep 15, 2021) | ||
16-18866676-T-C | not specified | Likely benign (Aug 13, 2021) | ||
16-18866729-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
16-18869141-T-C | Benign (Mar 01, 2018) | |||
16-18869926-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
16-18871408-G-C | not specified | Uncertain significance (Aug 12, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMG1 | protein_coding | protein_coding | ENST00000446231 | 63 | 121602 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 1.30e-25 | 124651 | 0 | 6 | 124657 | 0.0000241 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.30 | 1372 | 1.76e+3 | 0.779 | 0.0000937 | 23799 |
Missense in Polyphen | 424 | 736.79 | 0.57547 | 10252 | ||
Synonymous | -2.76 | 736 | 647 | 1.14 | 0.0000357 | 7024 |
Loss of Function | 11.9 | 4 | 172 | 0.0232 | 0.00000908 | 2272 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000928 | 0.0000928 |
European (Non-Finnish) | 0.0000355 | 0.0000354 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine protein kinase involved in both mRNA surveillance and genotoxic stress response pathways. Recognizes the substrate consensus sequence [ST]-Q. Plays a central role in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons by phosphorylating UPF1/RENT1. Recruited by release factors to stalled ribosomes together with SMG8 and SMG9 (forming the SMG1C protein kinase complex), and UPF1 to form the transient SURF (SMG1-UPF1-eRF1-eRF3) complex. In EJC-dependent NMD, the SURF complex associates with the exon junction complex (EJC) through UPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillance complex which is believed to activate NMD. Also acts as a genotoxic stress-activated protein kinase that displays some functional overlap with ATM. Can phosphorylate p53/TP53 and is required for optimal p53/TP53 activation after cellular exposure to genotoxic stress. Its depletion leads to spontaneous DNA damage and increased sensitivity to ionizing radiation (IR). May activate PRKCI but not PRKCZ. {ECO:0000269|PubMed:11331269, ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:15175154, ECO:0000269|PubMed:16452507}.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -2.98
- rvis_percentile_EVS
- 0.54
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.760
- ghis
- 0.628
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.818
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Smg1
- Phenotype
- craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; neoplasm;
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;DNA repair;mRNA export from nucleus;peptidyl-serine phosphorylation;regulation of telomere maintenance;protein autophosphorylation;phosphatidylinositol phosphorylation;regulation of response to DNA damage stimulus
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol
- Molecular function
- RNA binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;telomeric DNA binding;metal ion binding